Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Revenue (2021 - 2023)

Senti Biosciences (SNTI) has 3 years of Revenue data on record, last reported at -$333000.0 in Q4 2023.

  • For Q4 2023, Revenue fell 664.41% year-over-year to -$333000.0; the TTM value through Sep 2024 reached -$333000.0, down 114.05%, while the annual FY2023 figure was $2.0 million, 53.85% down from the prior year.
  • Revenue reached -$333000.0 in Q4 2023 per SNTI's latest filing, down from $338000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.8 million in Q3 2022 and bottomed at -$333000.0 in Q4 2023.
  • Average Revenue over 3 years is $725727.3, with a median of $937000.0 recorded in 2023.
  • Peak YoY movement for Revenue: skyrocketed 897.74% in 2022, then tumbled 664.41% in 2023.
  • A 3-year view of Revenue shows it stood at $1.0 million in 2021, then plummeted by 94.18% to $59000.0 in 2022, then crashed by 664.41% to -$333000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Revenue were -$333000.0 in Q4 2023, $338000.0 in Q3 2023, and $937000.0 in Q2 2023.